The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis

Our study aims to detect whether the serum RANKL could be a novel potential biomarker for activity and diagnosis of rheumatoid arthritis (RA). It included fifty-eight of RA patients and thirty of equal age and sex matched controls. Disease activity was determined by using DAS28-ESR. Serum Levels of...

Full description

Bibliographic Details
Main Authors: Rama Hussein, Imad Aboukhamis
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Biochemistry and Biophysics Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S240558082200173X
_version_ 1828338240303661056
author Rama Hussein
Imad Aboukhamis
author_facet Rama Hussein
Imad Aboukhamis
author_sort Rama Hussein
collection DOAJ
description Our study aims to detect whether the serum RANKL could be a novel potential biomarker for activity and diagnosis of rheumatoid arthritis (RA). It included fifty-eight of RA patients and thirty of equal age and sex matched controls. Disease activity was determined by using DAS28-ESR. Serum Levels of RANKL were assayed by ELISA and compared with parameters such as ESR, CRP, Rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPA). The serum RANKL levels were higher in RA patients compared to controls. There was an increase in its levels mean among post-menopausal patients compared to post-menopausal healthy group. RANKL levels were also higher in ACPA positive patients than ACPA negative. Our study found a correlation between RANKL levels and some parameters: DAS28, ACPA, CRP, and symptom duration. There was a moderate inverse correlation between RANKL levels and BMD. By ROC curve, our results displayed that the best cut-off value of RANKL was 178.99 pg/ml (sensitivity 79.31%; specificity 90%) to differentiate between RA patients and controls. In conclusion, elevated serum RANKL can be used as an indicator of disease activity and a diagnostic new biomarker in patients with early RA.
first_indexed 2024-04-13T22:26:12Z
format Article
id doaj.art-d22b8ef69a944025addc3255c0fe5e3f
institution Directory Open Access Journal
issn 2405-5808
language English
last_indexed 2024-04-13T22:26:12Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Biochemistry and Biophysics Reports
spelling doaj.art-d22b8ef69a944025addc3255c0fe5e3f2022-12-22T02:27:04ZengElsevierBiochemistry and Biophysics Reports2405-58082022-12-0132101373The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritisRama Hussein0Imad Aboukhamis1Department of Microbiology, Hematology and Immunology, Faculty of Pharmacy, Damascus University, Syria; Corresponding author.Department of Microbiology, Hematology and Immunology, Faculty of Pharmacy, Damascus University, Syria; Department of Hematology and Immunology, Faculty of Pharmacy, Damascus University, SyriaOur study aims to detect whether the serum RANKL could be a novel potential biomarker for activity and diagnosis of rheumatoid arthritis (RA). It included fifty-eight of RA patients and thirty of equal age and sex matched controls. Disease activity was determined by using DAS28-ESR. Serum Levels of RANKL were assayed by ELISA and compared with parameters such as ESR, CRP, Rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPA). The serum RANKL levels were higher in RA patients compared to controls. There was an increase in its levels mean among post-menopausal patients compared to post-menopausal healthy group. RANKL levels were also higher in ACPA positive patients than ACPA negative. Our study found a correlation between RANKL levels and some parameters: DAS28, ACPA, CRP, and symptom duration. There was a moderate inverse correlation between RANKL levels and BMD. By ROC curve, our results displayed that the best cut-off value of RANKL was 178.99 pg/ml (sensitivity 79.31%; specificity 90%) to differentiate between RA patients and controls. In conclusion, elevated serum RANKL can be used as an indicator of disease activity and a diagnostic new biomarker in patients with early RA.http://www.sciencedirect.com/science/article/pii/S240558082200173XRheumatoid arthritisSerum RANKLDisease activityParameters
spellingShingle Rama Hussein
Imad Aboukhamis
The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis
Biochemistry and Biophysics Reports
Rheumatoid arthritis
Serum RANKL
Disease activity
Parameters
title The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis
title_full The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis
title_fullStr The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis
title_full_unstemmed The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis
title_short The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis
title_sort association of serum rankl levels with disease activity and hematological parameters in syrian patients with rheumatoid arthritis
topic Rheumatoid arthritis
Serum RANKL
Disease activity
Parameters
url http://www.sciencedirect.com/science/article/pii/S240558082200173X
work_keys_str_mv AT ramahussein theassociationofserumrankllevelswithdiseaseactivityandhematologicalparametersinsyrianpatientswithrheumatoidarthritis
AT imadaboukhamis theassociationofserumrankllevelswithdiseaseactivityandhematologicalparametersinsyrianpatientswithrheumatoidarthritis
AT ramahussein associationofserumrankllevelswithdiseaseactivityandhematologicalparametersinsyrianpatientswithrheumatoidarthritis
AT imadaboukhamis associationofserumrankllevelswithdiseaseactivityandhematologicalparametersinsyrianpatientswithrheumatoidarthritis